When you buy Survodutide, you are investing in a peptide that incorporates structural modifications to the human glucagon sequence, including a non-coded amino acid (1-aminocyclobutane-1-carboxylic acid) at position 2 to enhance proteolytic stability and a C18 fatty acid moiety to prolong half-life through albumin binding. The peptide’s dual receptor engagement enables synergistic mechanisms that influence metabolic pathways, including regulation of insulin and glucagon secretion, inhibition of food intake, and modulation of metabolic function. Research has shown that Survodutide acts through circumventricular organs in the brain, activating neuronal regions associated with appetite regulation. The GLP-1R component is expressed in human circumventricular organs, where the peptide can access and modulate feeding behavior. Scientists who buy Survodutide can explore these sophisticated mechanisms in their laboratory studies.
[Image 3: Research Applications Infographic]
Alt: Survodutide research applications for metabolic and liver studies when you buy Survodutide
Key Research Applications When You Buy Survodutide
Obesity and Weight Management Research
When you buy Survodutide for obesity research, you join scientists investigating the Phase 3 SYNCHRONIZE-1 trial results showing significant weight reduction with mean changes of -12.2% at the 3.6 mg dose and -13.0% at the 6.0 mg dose over 76 weeks, compared to -5.4% with placebo. Up to 72.6% of participants achieved at least 5% weight reduction. Researchers who buy Survodutide can investigate these powerful weight management mechanisms.
Liver and Metabolic Research
Researchers who buy Survodutide can investigate its effects on liver health, as the SYNCHRONIZE-MASLD trial showed up to 84.2% of patients achieved liver fat reduction of at least 30%. The peptide reduced visceral fat by up to 34% and liver fat by up to 63.1% from baseline. When you buy Survodutide, you gain access to a compound with remarkable liver-directed research potential.
Body Composition Studies
Survodutide demonstrates targeted fat reduction with lean mass accounting for no more than 10.8% of body composition change at the highest dose, suggesting weight loss is driven primarily by fat reduction. Scientists who buy Survodutide can explore these body composition effects in their research models.
Cardiometabolic Research
Survodutide has shown improvements in waist circumference, blood pressure, glycemic control, and lipid metabolism markers. When you buy Survodutide, you can investigate these comprehensive cardiometabolic effects.
[Image 4: HPLC Purity Analysis Chart]
Alt: HPLC chromatogram showing Survodutide peptide purity with Certificates of Analysis when you buy Survodutide
[Image 5: Certificate of Analysis Sample]
Alt: Sample COA included when you purchase Survodutide from our catalog
Product Specifications for Survodutide
| Specification | Detail |
|---|---|
| Peptide Name | Survodutide (BI 456906) |
| Sequence | H-{1-Aminocyclobutanecarboxylic acid}-QGTFTSDYSKYLDERAAKDFI-{Lys(GSGSGG-γGlu-C18 diacid)}-WLESA-NH2 |
| Length | 29 amino acids |
| Molecular Formula | C192H289N47O61 |
| Molecular Weight | 4231.63 g/mol |
| CAS Number | 2805997-46-8 |
| Purity | ≥98% by HPLC |
| Form | Lyophilized powder |
| Storage | -20°C, protected from light |
| Intended Use | Laboratory Research Use Only |
When you buy Survodutide with these specifications, your research is built on a foundation of reliability and batch-to-batch consistency.
Proper Storage and Handling After You Buy Survodutide
To maximize research outcomes after you buy Survodutide, follow these essential guidelines:
-
Store lyophilized peptide at -20°C, protected from light
-
Allow the vial to reach room temperature before opening to prevent condensation
-
Reconstitute with appropriate buffer
-
Aliquot to avoid repeated freeze-thaw cycles
-
Handle with care as Survodutide is light-sensitive
-
Use within 28 days after reconstitution when stored at 2-8°C
[Internal Link: Download Complete Storage Protocol]
[Internal Link: View FAQ on Peptide Reconstitution]
Regulatory and Clinical Significance
Survodutide is being evaluated in a comprehensive Phase 3 program including SYNCHRONIZE-1 (obesity without diabetes), SYNCHRONIZE-2 (obesity with type 2 diabetes), SYNCHRONIZE-MASLD (obesity with liver disease), and SYNCHRONIZE-CVOT (cardiovascular outcomes). The LIVERAGE program is investigating Survodutide in adults with MASH and fibrosis, enrolling approximately 1,800 participants. When you buy Survodutide for your laboratory, you join researchers exploring this compound’s potential across numerous metabolic disease models.
[Image 6: Research Applications Graphic]
Alt: Metabolic research applications when you order Survodutide peptides
[Image 7: Storage and Handling Infographic]
Alt: Proper storage instructions for Survodutide peptide after purchase
[Image 8: Shipping and Packaging Image]
Alt: Temperature-controlled packaging for Survodutide peptide orders
Why Choose Us When You Buy Survodutide?
Uncompromising Purity
When you buy Survodutide from us, every batch undergoes rigorous HPLC and mass spectrometry verification with ≥98% purity.
Third-Party Testing
Independent laboratories verify potency, identity, and composition before any product reaches our inventory.
Batch-Specific Documentation
Every researcher who chooses to buy Survodutide receives complete COAs tied to specific production lots.
Expert Scientific Support
Our team is available for research consultations, protocol guidance, and product selection assistance.
Fast Fulfillment
Orders placed before 3 PM CST ship the same business day.
Mix & Match Savings
Save 10% on 3+ vials, 15% on 5+ vials, 20% on 8+ vials, and 25% on 15+ vials.
[Internal Link: Add Survodutide to Your Cart Now]
[Internal Link: View Our Complete Product Catalog]
[Internal Link: Create Your Account for Exclusive Benefits]
Compliance and Important Notice
All products, including Survodutide, are offered for in-vitro laboratory research purposes only. These compounds are not drugs, foods, cosmetics, diagnostic products, or dietary supplements. By purchasing, you represent and warrant that products will be used solely for in-vitro research by qualified professionals. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
[External Link: NEJM – Survodutide Phase 3 Trial Results]
[External Link: Nature Medicine – SYNCHRONIZE-MASLD Study]
[External Link: ClinicalTrials.gov – SYNCHRONIZE-1 Trial]
[External Link: FDA – Research Compound Guidelines]
[External Link: National Institute on Aging – Metabolic Research]
[External Link: American Heart Association – Cardiometabolic Health]
[External Link: NIH PubMed – Survodutide Research Publications]
[External Link: European Medicines Agency – Research Guidelines]
[External Link: National Institutes of Health – Research Resources]
[External Link: FTC Advertising Substantiation Guidelines]



Reviews
There are no reviews yet.